# Actavis Laboratories UT, Inc., Salt Lake City, UT – FDA Inspections

Source: https://www.keypedia.com/companies/actavis-laboratories-ut-inc/cbe6c043-14c7-4f58-84bf-68647da581f8

> Inspection records and compliance data for Actavis Laboratories UT, Inc. in Salt Lake City, Utah. 13 FDA inspections on record (1 OAI), 2 Form 483s, last inspected September 19, 2025.

---

## Details

- Name: Actavis Laboratories UT, Inc.
- FEI Number: 1000117147
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK
- Address Line 1: 577 S Chipeta Way
- City: Salt Lake City
- State: Utah
- Zip Code: 84108
- Country Name: United States
- Address: 577 S Chipeta Way, Salt Lake City, Utah 84108, United States
- Country: United States

## Related Documents

- [483 - Actavis Laboratories UT, Inc. - 2025-09-19](https://www.keypedia.com/records/483/actavis-laboratories-ut-inc/9bbbce85-4dac-4aa0-9a06-b6137bba0dac) — source: FDA, date: September 19, 2025
- [FDA Inspection 1282698 - Actavis Laboratories UT, Inc. - 2025-09-19](https://www.keypedia.com/records/fda_inspections/actavis-laboratories-ut-inc/551c111b-91a0-4aa0-a48c-8f38beb28459) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 19, 2025
- [483 - Actavis Laboratories UT, Inc. - 2024-03-19](https://www.keypedia.com/records/483/actavis-laboratories-ut-inc/30da6e40-2e6e-45aa-88f1-15bfb9f5e13a) — source: FDA, date: March 19, 2024
- [FDA Inspection 1230375 - Actavis Laboratories UT, Inc. - 2024-03-19](https://www.keypedia.com/records/fda_inspections/actavis-laboratories-ut-inc/a5b24e08-bafd-4420-b1f1-8810ef77e4a8) — classification: Official Action Indicated (OAI), source: FDA, date: March 19, 2024
- [483 - Actavis Laboratories UT, Inc. - 2021-08-20](https://www.keypedia.com/records/483/actavis-laboratories-ut-inc/101cbdfb-b214-4afb-b2fc-acfe03827d83) — source: FDA, date: August 20, 2021
- [FDA Inspection 1149636 - Actavis Laboratories UT, Inc. - 2021-08-20](https://www.keypedia.com/records/fda_inspections/actavis-laboratories-ut-inc/f9b7701a-aaf6-4b31-af9a-83201c751965) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 20, 2021
- [EIR - Actavis Laboratories UT, Inc. - 2021-06-20](https://www.keypedia.com/records/eir/actavis-laboratories-ut-inc/8cb7648c-9839-447b-9fa3-3c160aa4a019) — source: FDA, date: June 20, 2021
- FDA Inspection 1065736 - Actavis Laboratories UT, Inc. - 2018-08-02 — classification: No Action Indicated (NAI), source: FDA, date: August 2, 2018
- FDA Inspection 1035181 - Actavis Laboratories UT, Inc. - 2017-10-25 — classification: No Action Indicated (NAI), source: FDA, date: October 25, 2017
- [FDA Inspection 1012979 - Actavis Laboratories UT, Inc. - 2017-05-19](https://www.keypedia.com/records/fda_inspections/actavis-laboratories-ut-inc/5d4cbaa5-e36a-4b3c-be00-ba6f07176ee8) — source: FDA, date: May 19, 2017
- FDA Inspection 953640 - Actavis Laboratories UT, Inc. - 2015-12-08 — classification: No Action Indicated (NAI), source: FDA, date: December 8, 2015
- [FDA Inspection 900144 - Actavis Laboratories UT, Inc. - 2014-10-17](https://www.keypedia.com/records/fda_inspections/actavis-laboratories-ut-inc/89c1dad9-e971-41cb-a15b-a1cff542e797) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 17, 2014
- FDA Inspection 875107 - Actavis Laboratories UT, Inc. - 2014-01-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 17, 2014
- FDA Inspection 810914 - Actavis Laboratories UT, Inc. - 2012-12-14 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 14, 2012

## Related Companies

- [KP Pharmaceutical Technology](https://www.keypedia.com/companies/kp-pharmaceutical-technology/acd7d203-2bd2-4702-a902-83c45f57890f)
- [Abraxis Bioscience, LLC](https://www.keypedia.com/companies/abraxis-bioscience-llc/5751a531-276f-4635-9289-30cacf498d86)
- [Pfizer Manufacturing Deutschland GmbH](https://www.keypedia.com/companies/pfizer-manufacturing-deutschland-gmbh/0847af94-33df-4d46-bba1-0c664ea47d08)
- [AbbVie Ltd](https://www.keypedia.com/companies/abbvie-ltd/b07cdd9b-e7d5-4b8b-b31d-3cc5dd0c3775)
- [TOLMAR, Inc.](https://www.keypedia.com/companies/tolmar-inc/a73dea00-baea-4f0e-8234-c0becc61322e)
- [Corium Innovations, Inc.](https://www.keypedia.com/companies/corium-innovations-inc/6ef69358-81bb-44a9-a576-41a1c5d94783)
- [United Therapeutics Corporation](https://www.keypedia.com/companies/united-therapeutics-corporation/5f83ecf2-e9e1-408a-9a1b-b381eac864a1)
- [Societal CDMO Gainesville, LLC](https://www.keypedia.com/companies/societal-cdmo-gainesville-llc/6a502520-0ac5-48a2-ac38-7b93e63598cb)
- [Tulex Pharmaceuticals Inc.](https://www.keypedia.com/companies/tulex-pharmaceuticals-inc/e9839d9b-b973-49c3-916a-4ca187d606dd)
- [KVK Tech, Inc.](https://www.keypedia.com/companies/kvk-tech-inc/f8ea60fc-cfc0-4769-8e62-a677abd59cb9)

## Related Officers

- [Consumer Safety Officer](https://www.keypedia.com/people/dustin-m-james/bf423ddc-721b-4049-9eb1-3bc0fdb44441)
- [Consumer Safety Officer (Drug Specialist)](https://www.keypedia.com/people/alan-p-kurtzberg/36ee316e-6d19-44b2-a131-fc254ada4f41)
- [Santos E. Camara](https://www.keypedia.com/people/santos-e-camara/18cea942-f6f9-4dec-9ce9-1c01c39009ce)
- [Joan M. Cantellops Figueroa](https://www.keypedia.com/people/joan-m-cantellops-figueroa/f791fcd2-a5d4-41e8-a8f2-96569096b422)
